Cargando…

Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment

Therapeutic advance in progressive multiple sclerosis (MS) has been very slow. Based on the transformative role magnetic resonance imaging (MRI) contrast-enhancing lesions had on drug development for relapsing-remitting MS, we consider the lack of sensitive outcomes to be the greatest barrier for de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosa, Peter, Ghazali, Danish, Tanigawa, Makoto, Barbour, Chris, Cortese, Irene, Kelley, William, Snyder, Blake, Ohayon, Joan, Fenton, Kaylan, Lehky, Tanya, Wu, Tianxia, Greenwood, Mark, Nair, Govind, Bielekova, Bibiana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983704/ https://www.ncbi.nlm.nih.gov/pubmed/27574516 http://dx.doi.org/10.3389/fneur.2016.00131

Ejemplares similares

Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
por: Komori, Mika, et al.
Publicado: (2016)

Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis
por: Tanigawa, Makoto, et al.
Publicado: (2017)

Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms
por: Kosa, Peter, et al.
Publicado: (2022)

Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping
por: Hannikainen, Paavali A., et al.
Publicado: (2020)

NeurEx: digitalized neurological examination offers a novel high‐resolution disability scale
por: Kosa, Peter, et al.
Publicado: (2018)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes
por: Natrajan, Muktha S., et al.
Publicado: (2015)

Digital droplet PCR for precise quantification of human T-lymphotropic virus 1 proviral loads
por: Brunetto, Giovanna S, et al.
Publicado: (2014)

Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis
por: Lin, Yen Chih, et al.
Publicado: (2015)

Pharmacodynamic effects of daclizumab in the intrathecal compartment
por: Komori, Mika, et al.
Publicado: (2017)

Confounder-adjusted MRI-based predictors of multiple sclerosis disability
por: Kim, Yujin, et al.
Publicado: (2022)

Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory Activity
por: Masvekar, Ruturaj, et al.
Publicado: (2021)

Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability
por: Mina, Yair, et al.
Publicado: (2021)

New Multiple Sclerosis Disease Severity Scale Predicts Future Accumulation of Disability
por: Weideman, Ann Marie, et al.
Publicado: (2017)

Intrathecal B Cells in MS Have Significantly Greater Lymphangiogenic Potential Compared to B Cells Derived From Non-MS Subjects
por: Stein, Jason, et al.
Publicado: (2018)

Idebenone does not inhibit disability progression in primary progressive MS
por: Kosa, Peter, et al.
Publicado: (2020)

Clinical trial of a humanized monoclonal anti-IL15Rβ (CD122), in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP)
por: Massoud, Raya, et al.
Publicado: (2014)

Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosis
por: Pham, Linh, et al.
Publicado: (2021)

Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutations
por: Brunetto, Giovanna S., et al.
Publicado: (2014)

Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation
por: Bielekova, Bibiana, et al.
Publicado: (2012)

1820. Efficacy of Pulse-Taper Corticosteroid Adjunctive Therapy for Refractory Non-HIV Cryptococcal Meningoencephalitis
por: Anjum, Seher, et al.
Publicado: (2019)

Machine learning-optimized Combinatorial MRI scale (COMRISv2) correlates highly with cognitive and physical disability scales in Multiple Sclerosis patients
por: Kelly, Erin, et al.
Publicado: (2022)

Assessment of Smartphone-Based Spiral Tracing in Multiple Sclerosis Reveals Intra-Individual Reproducibility as a Major Determinant of the Clinical Utility of the Digital Test
por: Messan, Komi S., et al.
Publicado: (2022)

Coinfection of Human Herpesviruses 6A (HHV-6A) and HHV-6B as Demonstrated by Novel Digital Droplet PCR Assay
por: Leibovitch, Emily C., et al.
Publicado: (2014)

A Complex Role of Herpes Viruses in the Disease Process of Multiple Sclerosis
por: Wuest, Simone C., et al.
Publicado: (2014)

Smartphone Level Test Measures Disability in Several Neurological Domains for Patients With Multiple Sclerosis
por: Boukhvalova, Alexandra K., et al.
Publicado: (2019)

Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments
por: Weideman, Ann Marie, et al.
Publicado: (2017)

Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination
por: Lin, Yen Chih, et al.
Publicado: (2016)

Juvenile Amyotrophic Lateral Sclerosis: A Review
por: Lehky, Tanya, et al.
Publicado: (2021)

Current Status and Future Opportunities in Modeling Clinical Characteristics of Multiple Sclerosis
por: Liu, Joshua, et al.
Publicado: (2022)

Biomarkers in Multiple Sclerosis
por: Martin, Roland, et al.
Publicado: (2006)

Enhancing the clinical value of serum neurofilament light chain measurement
por: Kosa, Peter, et al.
Publicado: (2022)

Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
por: Zhang, Yinan, et al.
Publicado: (2020)

Identifying and Quantifying Neurological Disability via Smartphone
por: Boukhvalova, Alexandra K., et al.
Publicado: (2018)

Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS)
por: Jia, Yan, et al.
Publicado: (2012)

Quantifications of CSF Apoptotic Bodies Do Not Provide Clinical Value in Multiple Sclerosis
por: Masvekar, Ruturaj, et al.
Publicado: (2019)

Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course
por: Castro, Kamilah, et al.
Publicado: (2019)

How Implementation of Systems Biology into Clinical Trials Accelerates Understanding of Diseases
por: Bielekova, Bibiana, et al.
Publicado: (2014)

Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling()
por: Jones, Blake C., et al.
Publicado: (2013)

Patterns of spinal cord atrophy in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP)
por: Charlip, Emily, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l61na2pbsn7vgejmuvo10q4oik